Hospitalar 2025 Wraps Up Successfully: WINMEDIC Highlights Pathology Innovation - Bulk Cloned
On May 23, 2025, Hospitalar 2025 — the much-anticipated international medical device exhibition in the global healthcare industry — came to a successful close at the São Paulo Expo in Brazil.
The exhibition featured participation from over 1,200 exhibitors representing more than 60 countries, highlighting the latest innovations in medical technology and sharing thought leadership from key industry figures. The event created exceptional opportunities for international cooperation and cross-border engagement among diverse stakeholders.
Dr. Waleska Santos, Founder and President of Hospitalar, remarked during the opening ceremony, “For more than 30 years, Hospitalar has been a central meeting point for the healthcare industry. By aligning public policy with industry needs, we have continuously worked to expand access to medical technology on a broad scale.”
Throughout the exhibition, a wide range of professional conferences and forums took place. Hundreds of experts and scholars, along with thousands of attendees, engaged in in-depth discussions on global medical research breakthroughs, emerging development trends, and the challenges and opportunities surrounding innovation, universal healthcare access, and international collaboration. Topics covered included smart healthcare, telemedicine, medical big data, and AI-assisted diagnostics, with the exchange of ideas helping to shape the future direction of the industry.
At Hospitalar 2025, WINMEDIC showcased its cutting-edge digital pathology solutions, drawing significant attention from attendees. The Win-Pro series digital slide scanners, in particular, were highly praised by experts and industry professionals for their exceptional imaging precision, rapid scanning speed, and the robust image-processing capabilities of the WinQuant multifunctional pathological image analysis software. Numerous visitors stopped by the booth to experience the scanners’ fast and accurate performance and intelligent analysis features. Many noted that the technology presents an innovative approach to improving the efficiency and accuracy of pathological diagnosis.
Looking ahead, WINMEDIC remains committed to advancing innovation and research in the field of digital pathology while accelerating the implementation of its global market strategy. By maintaining a strong focus on the practical needs of digital pathology applications, the company aims to deliver more innovative, efficient, and comprehensive end-to-end pathological solutions to customers around the world.
